JP Morgan Chase
CRL icon

JP Morgan Chase’s Charles River Laboratories CRL Stock Holding History

JP Morgan Chase’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-25,400
Closed -$6M – 7478
2023
Q4 		$6M Buy
+25,400
New +$5M ﹤0.01% 2925
2022
Q2 		– Sell
-109,400
Closed -$31.1M – 6519
2022
Q1 		$31.1M Buy
+109,400
New +$33.7M ﹤0.01% 1441
2013
Q4 		– Sell
-500,000
Closed -$23.1M – 4112
2013
Q3 		$23.1M Buy
+500,000
New +$22.9M 0.01% 1249

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase's CRL Position: Q1 2026 in Review

JP Morgan Chase increased its Charles River Laboratories (CRL) stake by 51% in Q1 2026, buying an estimated $16.6M and bringing the position to 264,350 shares worth $42.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1498.

JP Morgan Chase first reported a position in CRL in Q2 2013 and has held it in 52 quarters since. The position peaked at $114M in Q1 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • JP Morgan Chase held 264,350 shares of Charles River Laboratories worth $42.2M as of Q1 2026.
  • JP Morgan Chase bought 89,582 Charles River Laboratories shares in Q1 2026, an estimated $16.6M.
  • Charles River Laboratories made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1498 holding.
  • JP Morgan Chase first reported a position in Charles River Laboratories in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Charles River Laboratories position peaked at $114M in Q1 2025.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.